Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Sales (2017 - 2025)

Assembly Biosciences has reported Return on Sales over the past 9 years, most recently at 0.52% for Q4 2025.

  • Quarterly results put Return on Sales at 0.52% for Q4 2025, up 192.0% from a year ago — trailing twelve months through Dec 2025 was 0.08% (up 132.0% YoY), and the annual figure for FY2025 was 0.08%, up 132.0%.
  • Return on Sales for Q4 2025 was 0.52% at Assembly Biosciences, up from 0.85% in the prior quarter.
  • Over the last five years, Return on Sales for ASMB hit a ceiling of 0.52% in Q4 2025 and a floor of 21.17% in Q4 2021.
  • Median Return on Sales over the past 5 years was 1.4% (2024), compared with a mean of 5.22%.
  • Biggest five-year swings in Return on Sales: soared 1684bps in 2021 and later crashed -1968bps in 2022.
  • Assembly Biosciences' Return on Sales stood at 21.17% in 2021, then rose by 2bps to 20.65% in 2022, then soared by 93bps to 1.53% in 2023, then grew by 8bps to 1.4% in 2024, then soared by 137bps to 0.52% in 2025.
  • The last three reported values for Return on Sales were 0.52% (Q4 2025), 0.85% (Q3 2025), and 1.06% (Q2 2025) per Business Quant data.